Guido Ghilardi

7PUBLICATIONS
95CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 04, 2026
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells.

Ivan J Cohen, Audrey C Bochi-Layec, Jean Lemoine

|Oct 22, 2025
CD19 CAR T-Cell Therapy in Richter Transformation: A Multicentre Retrospective Analysis by the European Research Initiative on Chronic Lymphocytic Leukaemia.

Ofrat Beyar-Katz, Ohad Benjamini, Julio Delgado

|Jan 24, 2025
Association of age, race, and ethnicity with access, response, and toxicities from CAR-T therapy in children and adults with B-cell malignancies: a review.

Guido Ghilardi, Zainul S Hasanali, Sandra P Susanibar-Adaniya

|Jul 19, 2024
CD5 deletion enhances the antitumor activity of adoptive T cell therapies.

Ruchi P Patel, Guido Ghilardi, Yunlin Zhang

|Jul 29, 2022
Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer.

Yong Gu Lee, Puneeth Guruprasad, Guido Ghilardi

|Feb 25, 2022
Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study.

Sofia Genta, Guido Ghilardi, Luciano Cascione

Pageof 2

Frequent Collaborators

5 joint publications

Marco Ruella

4 joint publications

Stephen J Schuster

3 joint publications

Luca Paruzzo

3 joint publications

Patrizia Porazzi